U.S. Looks to Introduce European-Style Drug Price Controls

Meena Datta examines proposed new legislation that would authorise the Health and Human Services Secretary to negotiate prices directly with prescription drug manufacturers.

(more…)

Moves to Lower Drug Prices in Biden’s Executive Order on Competitiveness

This month’s presidential Executive Order on economic competitiveness in the U.S. includes a number of initiatives relating to drug pricing. There are calls to combat “excessive pricing,” to reduce the cost of drugs to the Federal government, to address “price gouging” and to promote low-cost generics and biosimilars.

(more…)